Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
See Latest ArticlesEndoscopic treatment of vesicoureteral reflux: current practice and the need for multifactorial assessment
Therapeutic Advances in Urology, 09/23/09
Lackgren G et al. – A new approach to managing VUR may be considered, with treatment decisions based not only on the grade of reflux but also on factors such as age, sex, renal scarring and bladder dysfunction. Open surgery would be reserved only for use in the 10–15% of children not responding to endoscopic treatment and those with severe ureteral anomalies.
Related Articles
Predictive Factors for Vesicoureteral Reflux and Prenatally Diagnosed Renal Pelvic Dilatation
The Journal of Urology, 10/29/09
Relevance Score: 69%
Abnormal renal scans and decreased early resolution of low grade vesicoureteral reflux
International Braz J Urol, 11/04/09
Relevance Score: 68%
Nomograms for Predicting Annual Resolution Rate of Primary Vesicoureteral Reflux: Results From 2,462 Children
The Journal of Urology, 10/01/09
Relevance Score: 68%
Diagnosis and management of vesicoureteral reflux in children
NCP Urology, 10/06/09
Relevance Score: 67%
Change of Urodynamic Patterns in Infants With Dilating Vesicoureteral Reflux: 3-Year Followup
The Journal of Urology, 10/30/09
Relevance Score: 66%
Today in Voiding Dys/Incontinence...keeping you current
Receive free subspecialty "5-minute updates" via email
Efficacy, tolerability and safety of propiverine hydrochloride in comparison to oxybutynin in children with urge incontinence due to overactive bladder: Results of a multicentre observational cohort study
BJU International, 12/14/09
The effect of gender on response to bacillus Calmette-Guerin therapy for patients with non-muscle-invasive urothelial carcinoma of the bladder
BJU International, 12/14/09
Treatment of Neurogenic Detrusor Overactivity with Botulinum Toxin A: The First Seven Years
Urologia Internationalis, 12/14/09
Article Search
Sponsor